New Delhi – In a significant policy shift aimed at safeguarding both public health and the national exchequer, the Union Government has introduced legislation to overhaul the taxation structure for tobacco and pan masala. As the Goods and Services Tax (GST) compensation cess nears its expiration, Finance Minister Nirmala Sitharaman has tabled two pivotal bills—the Health and National Security Cess Bill, 2025 and the Central Excise (Amendment) Bill, 2025—designed to ensure that “sin goods” remain heavily taxed.
The move comes as the government prepares to retire the GST compensation levy, originally introduced in 2017 to reimburse states for revenue losses, which is set to lapse in March 2026 or sooner upon full repayment of pandemic-era loans. The new legislative framework aims to prevent a sharp drop in tobacco prices, a scenario public health experts warn could trigger a surge in consumption.
The New Tax Architecture: From Compensation to Health Security
Under the proposed regime, the expiring compensation cess will be replaced by a two-pronged approach:
-
Steep Excise Duty Hikes: The Central Excise (Amendment) Bill proposes significantly higher excise duties on cigarettes, cigars, and unmanufactured tobacco. For instance, the duty on unmanufactured tobacco could see an increase to 60-70%, while specific duties on cigarettes will be adjusted based on length and filter status to maintain the current price barrier.
-
Capacity-Based Cess for Pan Masala: The Health and National Security Cess Bill introduces a unique levy on pan masala and gutkha manufacturers based on their machine production capacity rather than actual reported output. This measure is specifically designed to plug tax evasion loopholes rampant in the unorganized sector.
“The objective is revenue neutrality and health protection,” a senior official from the Finance Ministry stated on background. “We cannot afford a situation where the expiration of the compensation cess leads to cheaper cigarettes and gutkha. These bills ensure the tax incidence remains high, with the additional revenue earmarked for financing national health and security infrastructure.”
A Public Health Imperative
The restructuring of tobacco taxes is not merely a fiscal exercise; it is a critical public health intervention. India is the second-largest consumer of tobacco globally, with the habit claiming an estimated 1.35 million lives annually.
Dr. Rijo M. John, a health economist and adjunct professor, explains the stakes: “Tobacco taxation is the single most effective tool for reducing consumption, especially among youth and low-income groups. If the compensation cess were to lapse without a replacement, prices would plummet, effectively handing the industry a discount at the cost of public health.”
According to the World Health Organization (WHO), the economic burden of tobacco-related diseases in India is staggering, estimated at over 1% of the country’s GDP. The direct medical costs of treating cancer, cardiovascular diseases, and respiratory illnesses caused by tobacco far outstrip the tax revenue generated from the sector.
Expert Perspectives
The medical community has largely welcomed the move but emphasizes the need for consistent increases in tax rates relative to inflation.
“While maintaining the current tax burden is a relief, we ideally need taxes to make these products less affordable over time,” says Dr. P.C. Gupta, Director of the Healis Sekhsaria Institute for Public Health. “The introduction of a ‘Health Cess’ is symbolic and significant. It acknowledges that this industry imposes a heavy cost on our healthcare system.”
However, some experts caution that the structure must be robust. “The shift to capacity-based taxation for pan masala is a smart move to curb evasion,” notes tax policy analyst Amit Bhagat. “But the government must ensure that the excise hikes on cigarettes are substantial enough to offset the removal of the cess completely, so the end consumer feels no price relief.”
Market Reaction and Industry Impact
The announcement triggered immediate reactions in the stock market, with shares of major tobacco manufacturers like ITC and Godfrey Phillips dipping as investors digested the news of sustained high taxation. The industry had arguably hoped for a lighter tax burden post-2026.
The new “Health and National Security Cess” will be credited to the Consolidated Fund of India and is intended to be a dedicated stream for funding public health initiatives—potentially including cancer treatment centers and tobacco cessation programs—and national security needs.
What This Means for the Consumer
For the average consumer, the message is clear: do not expect cigarettes or gutkha to become cheaper. The government is legally locking in high prices to discourage use.
“For a smoker, this means the cost of the habit will remain punitive,” says Dr. Gupta. “And from a medical standpoint, that is exactly where it needs to be. Every rupee increase in price correlates with a decrease in the number of cigarettes smoked.”
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Primary Legislation: The Health and National Security Cess Bill, 2025 and The Central Excise (Amendment) Bill, 2025, introduced in Lok Sabha, Parliament of India (December 1, 2025).